The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation

Authors
Publication date
1 January 2009
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Institutional Research Information System University of Turin

    redirect
    oaioai:iris.unito.it:2318/124907
    Last time updated on 18/04/2020